According to Healio, recent data reveals that maxillomandibular advancement was effective in treating patients with obstructive sleep apnea.
“Maxillomandibular advancement is a highly effective treatment for [obstructive sleep apnea (OSA)]. Preoperative severity of OSA is the most reliable predictor of outcome effect size and the likelihood of surgical success and cure,” Soroush Zaghi, MD, from the David Geffen School of Medicine at the University of California, Los Angeles, and colleagues wrote. “Those patients with the most severe measures of OSA tend to benefit to the greatest degree. Patients with less severe measures of OSA experience a smaller magnitude of change in [apnea-hypopnea index (AHI)] or [respiratory disturbance index (RDI)] postoperatively, but they have the highest chance of achieving surgical success and cure. Patients with high residual RDI and AHI scores (despite prior treatments by means of uvulopalatopharyngoplasty, partial glossectomy, and/or nasal surgery) are highly likely to benefit from management of OSA by means of [maxillomandibular advancement (MMA)].”